Insulin resistance, hyperinsulinaemia (either endogenous due to insulin resistance or exogenous due to administered insulin or insulin secretagogues) and elevated levels of IGF-1 reduce apoptosis and increase cell proliferation in target cells, leading to tumour development 36–79. Here, IGF1 is linked to Insulin resistance.